ArticleOne health (Amsterdam, Netherlands)2015
Absence of MERS-CoV antibodies in feral camels in Australia: Implications for the pathogen's origin and spread.
Article in One health (Amsterdam, Netherlands), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.
- A systematic review of MERS-CoV seroprevalence and RNA prevalence in dromedary camels: Implications for animal vaccination.Epidemics · 2019Pooled it
- Subversion of autophagy machinery and organelle-specific autophagy by SARS-CoV-2 and coronaviruses.Autophagy · 2023Review
- Unresolved questions in the zoonotic transmission of MERS.Current opinion in virology · 2022Review
- Coronavirus seroprevalence among villagers exposed to bats in Thailand.Zoonoses and public health · 2021Article
- Are environmental pollution and biodiversity levels associated to the spread and mortality of COVID-19? A four-month global analysis.Environmental pollution (Barking, Essex : 1987) · 2021Article
- MERS-CoV: epidemiology, molecular dynamics, therapeutics, and future challenges.Annals of clinical microbiology and antimicrobials · 2021Review
- Emergence of Bat-Related Betacoronaviruses: Hazard and Risks.Frontiers in microbiology · 2021Review
- One Health in the context of coronavirus outbreaks: A systematic literature review.One health (Amsterdam, Netherlands) · 2020Review
- Camelid Inoculation With Middle East Respiratory Syndrome Coronavirus: Experimental Models of Reservoir Host Infection.Viruses · 2020Review
- Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.Infectious diseases of poverty · 2020Review
- A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques.Science advances · 2020Article
- A Review of Zoonotic Pathogens of Dromedary Camels.EcoHealth · 2019Review
- Advancing Planetary Health in Australia: focus on emerging infections and antimicrobial resistance.BMJ global health · 2019Review
- Global status of Middle East respiratory syndrome coronavirus in dromedary camels: a systematic review - CORRIGENDUM.Epidemiology and infection · 2019Article
- Article
- Countrywide Survey for MERS-Coronavirus Antibodies in Dromedaries and Humans in Pakistan.Virologica Sinica · 2018Article
- Sero-prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) specific antibodies in dromedary camels in Tabuk, Saudi Arabia.Journal of medical virology · 2018Article
- An Opportunistic Pathogen Afforded Ample Opportunities: Middle East Respiratory Syndrome Coronavirus.Viruses · 2017Review
- No Serologic Evidence of Middle East Respiratory Syndrome Coronavirus Infection Among Camel Farmers Exposed to Highly Seropositive Camel Herds: A Household Linked Study, Kenya, 2013.The American journal of tropical medicine and hygiene · 2017Article
- Dromedary camels in northern Mali have high seropositivity to MERS-CoV.One health (Amsterdam, Netherlands) · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 7 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Middle East respiratory syndrome coronavirus (MERS-CoV) infections continue to be a serious emerging disease problem internationally with well over 1000 cases and a major outbreak outside of the Middle East region. While the hypothesis that dromedary camels are the likely major source of MERS-CoV infection in humans is gaining acceptance, conjecture continues over the original natural reservoir host(s) and specifically the role of bats in the emergence of the virus. Dromedary camels were imported to Australia, principally between 1880 and 1907 and have since become a large feral population inhabiting extensive parts of the continent. Here we report that during a focussed surveillance study, no serological evidence was found for the presence of MERS-CoV in the camels in the Australian population. This finding presents various hypotheses about the timing of the emergence and spread of MERS-CoV throughout populations of camels in Africa and Asia, which can be partially resolved by testing sera from camels from the original source region, which we have inferred was mainly northwestern Pakistan. In addition, we identify bat species which overlap (or neighbour) the range of the Australian camel population with a higher likelihood of carrying CoVs of the same lineage as MERS-CoV. Both of these proposed follow-on studies are examples of "proactive surveillance", a concept that has particular relevance to a One Health approach to emerging zoonotic diseases with a complex epidemiology and aetiology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.